April, 2019
For breast cancer screening and colorectal cancer screening, net transportation costs fall comfortably below the conventionally accepted $50,000 quality-adjusted life year (QALY) standard.
April, 2019
For influenza vaccinations, dental care, chronic obstructive pulmonary disease, hypertension, depression/mental health, and ESRD, improvements in life expenctancy or quality of life are easily large enough to justify increased net costs.
April, 2019
For prenatal care, asthma, congestive heart failure, and diabetes, improved transportation produces net cost savings.
April, 2019
While there is substantial uncertainty in the precise computations at the condition level, a strong case can be made that improved access to NEMT for transportation-disadvantaged persons is cost-effective in terms of better healthcare. In some cases, this cost-effectiveness translates directly into decreases in health care costs that exceed the added transportation costs. In other […]